Using Quantitative Bias Analysis to Adjust for Misclassification of COVID‐19 Outcomes: An Applied Example of Inhaled Corticosteroids and COVID‐19 Outcomes
Bokern M, Rentsch C, Quint J, Hunnicutt J, Douglas I, Schultze A. Using Quantitative Bias Analysis to Adjust for Misclassification of COVID‐19 Outcomes: An Applied Example of Inhaled Corticosteroids and COVID‐19 Outcomes. Pharmacoepidemiology And Drug Safety 2025, 34: e70086. PMID: 39776023, PMCID: PMC11706700, DOI: 10.1002/pds.70086.Peer-Reviewed Original ResearchConceptsProbabilistic bias analysisRisk of COVID-19 hospitalisationCOVID-19 hospitalisationChronic obstructive pulmonary diseaseOutcome misclassificationInhaled corticosteroid usersCOVID-19 outcomesIncreased risk of COVID-19 hospitalisationClinical Practice Research Datalink AurumInhaled CorticosteroidsLogistic regressionQuantitative bias analysisBias analysisTriple therapySummary-levelObstructive pulmonary diseaseImpact treatment effect estimates
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply